+30.4%
GSK vs GWRE
-25.4%
+55.8%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GWRE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -19.9% | +18.0% | -1.8% |
| 7D | -1.8% | -21.1% | +19.3% | -1.7% |
| 30D | -2.2% | +1.3% | -3.5% | -1.9% |
| 3M | -1.8% | +7.4% | -9.3% | -2.3% |
| 6M | -10.6% | +5.6% | -16.2% | -10.5% |
| YTD | +4.4% | -19.2% | +23.6% | +6.3% |
| 1Y | +30.4% | -25.1% | +55.6% | +31.9% |
| All | +30.4% | -25.4% | +55.8% | +31.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GWRE.
Daily Out/Under-Performance
Portfolio return minus GWRE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GWRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GWRE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling